Search clinical trials for: SOM 230 / Pasireotide
Total 5267 results
-
NYU Langone HealthTerminatedDuctal Carcinoma in SituUnited States
-
NYU Langone HealthUnited States Department of DefenseCompletedAtypical Ductal Breast Hyperplasia | Lobular Carcinoma in Situ (LCIS) | Atypical Lobular Hyperplasia (ALH) of BreastUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteNovartis Pharmaceuticals; RECORDATI GROUPCompletedNeuroendocrine Tumors | Carcinoid TumorsUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteNovartis PharmaceuticalsCompleted
-
Novartis PharmaceuticalsCompleted
-
Novartis PharmaceuticalsCompletedMetastatic Melanoma and Merkel Cell CarcinomaGermany, Switzerland
-
Novartis PharmaceuticalsCompletedGastroenteropancreatic Neuroendocrine Tumor of the Pulmonary ot Gastroenteropancreatic SystemGermany
-
RECORDATI GROUPRecruitingPost-Bariatric HypoglycemiaUnited States, Belgium, France, Italy, Spain, United Kingdom
-
Robert R. Henry, MDVeterans Medical Research FoundationCompletedHyperglycemiaUnited States
-
Patrick Y. Wen, MDMemorial Sloan Kettering Cancer Center; Massachusetts General Hospital; Northwestern... and other collaboratorsCompleted
-
Novartis PharmaceuticalsCompleted
-
Alliance Pour La Recherche en CancerologieCompleted
-
Milton S. Hershey Medical CenterWithdrawnMultiple MyelomaUnited States
-
Novartis PharmaceuticalsTerminatedPituitary Neoplasm | Pancreatic Neoplasm | Ectopic ACTH Syndrome | Nelson SyndromeGermany, Italy, Australia, Russian Federation, Spain, Thailand, France, Canada, Brazil, United States, Argentina, Mexico
-
Columbia UniversityTerminatedPituitary Tumor | ACTH-producing Pituitary TumourUnited States
-
Hospices Civils de LyonCompleted
-
Novartis PharmaceuticalsCompletedDose Escalation Study of Pasireotide (SOM230) in Patients With Advanced Neuroendocrine Tumors (NETs)Neuroendocrine TumorsUnited States
-
University of PennsylvaniaTerminatedGonadotroph AdenomasUnited States
-
UNC Lineberger Comprehensive Cancer CenterNovartis PharmaceuticalsCompletedEverolimus and Pasireotide (SOM230) in Patients With Advanced or Metastatic Hepatocellular CarcinomaAdvanced Adult Hepatocellular CarcinomaUnited States
-
Novartis PharmaceuticalsCompletedAcromegaly | Pituitary GigantismJapan
-
Mayo ClinicCompletedAutosomal Dominant Polycystic Kidney Disease | Polycystic Liver Disease | Autosomal Dominant Polycystic Liver Disease | Somatostatin AnalogsUnited States
-
Novartis PharmaceuticalsCompletedAcromegalyItaly, Belgium, United Kingdom, Bulgaria, Turkey, France, Portugal, China, Argentina, Brazil, Colombia, Hungary, Malaysia, Mexico, Romania
-
Lynn FeunCompletedHepatocellular CarcinomaUnited States
-
Novartis PharmaceuticalsCompletedNeuroendocrine Carcinoma of the Lung and ThymusItaly, United Kingdom, Netherlands, Spain, Germany, France, Greece, Denmark, Sweden
-
Yale UniversityJohns Hopkins University; University of Colorado, Denver; Northwestern University and other collaboratorsRecruitingInfertility | EndometriosisUnited States
-
University of PalermoCompleted
-
Novartis PharmaceuticalsCompletedDumping SyndromeBelgium, Netherlands, Germany, France, United States
-
Gustave Roussy, Cancer Campus, Grand ParisTerminated
-
Memorial Sloan Kettering Cancer CenterNovartis PharmaceuticalsCompletedPancreatic CancerUnited States
-
Novartis PharmaceuticalsApproved for marketing
-
Novartis PharmaceuticalsCompleted
-
Karyopharm Therapeutics IncWithdrawnDiabetic Foot UlcersNew Zealand
-
Yale UniversityUniversity of Colorado, Denver; Eunice Kennedy Shriver National Institute of... and other collaboratorsActive, not recruitingInfertility | EndometriosisUnited States
-
Icahn School of Medicine at Mount SinaiNational Institute of Mental Health (NIMH)RecruitingFirst Episode Psychosis (FEP) | Clinical High Risk for Psychosis (CHR)United States
-
Zealand University HospitalUnknownHypoglycemia, ReactiveDenmark
-
University of KentuckyInflammasome TherapeuticsRecruitingAge-Related Macular Degeneration | Geographic AtrophyUnited States
-
Novartis PharmaceuticalsCompletedCushing's DiseaseUnited States, Germany, Korea, Republic of, Spain, Thailand, Lebanon, Romania, Greece, Brazil, Russian Federation, Czechia
-
Montefiore Medical CenterNovartis PharmaceuticalsWithdrawnHyperinsulinism | Insulinoma | Congenital Hyperinsulinism
-
TakedaTakeda Development Center Americas, Inc.RecruitingCoagulation DisorderUnited States, Spain, Belgium, France, Netherlands
-
Novartis PharmaceuticalsCompletedCushing's DiseaseItaly, Belgium, Japan, Germany, United Kingdom, Thailand, Spain, France, Netherlands, Turkey, Israel, China, United States, Canada, India, Argentina, Brazil, Peru, Poland, Russian Federation
-
Erasmus Medical CenterNovartisUnknown
-
Memorial Sloan Kettering Cancer CenterNovartis PharmaceuticalsCompletedUveal MelanomaUnited States
-
Novartis PharmaceuticalsCompletedAcromegaly | Cushing's DiseaseUnited States, Turkey, Belgium, Thailand, Germany, Denmark, Russian Federation, Peru, China, Brazil, India, Poland
-
Novartis PharmaceuticalsTerminatedIslet Cell TumorFrance, Spain, United Kingdom, Belgium, Hungary, Turkey, Canada, Argentina, Sweden, Italy, Thailand, Germany, Netherlands, Brazil, Australia, Japan, United States, Denmark, New Zealand
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Novartis; Beth Israel Deaconess Medical Center; Brigham and Women's HospitalCompletedNeuroendocrine Tumor | Carcinoid Tumor | Pancreatic Neuroendocrine TumorUnited States
-
CicloMed LLCCmed Clinical ServicesCompletedAdvanced Solid TumorsUnited States
-
Nanfang Hospital, Southern Medical UniversityRecruitingEnd Stage Liver Disease | Portal Hypertension | Jaundice | Liver DysfunctionChina
-
Novartis PharmaceuticalsCompletedAcromegalyUnited States
-
Emory UniversityNovartisCompletedThyroid CancerUnited States
-
Helsinki University Central HospitalCompletedSurgical Complications